ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

SNY Sanofi

46.25
-1.28 (-2.69%)
14 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Sanofi SNY NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-1.28 -2.69% 46.25 23:00:11
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
46.80 45.90 46.85 46.25 47.53
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
11/6/202412:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/6/202406:00PRNUSI-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical..
31/5/202415:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
31/5/202400:05GLOBEDupixent® (dupilumab) Recommended for EU Approval by the..
31/5/202400:00GLOBEUpdate on FDA Priority Review of Dupixent® (dupilumab) for..
30/5/202415:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202411:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202409:34EDGAR2Form SD - Specialized disclosure report
23/5/202406:40IHMARKETNEWSOpenAI and News Corp Seal Partnership, DuPont de Nemours..
21/5/202406:18IHMARKETNEWSCalPERS to Oppose Exxon Mobil Directors; Microsoft Unveils..
13/5/202400:00GLOBEDupixent® (dupilumab) sBLA Accepted for FDA Priority Review..
10/5/202407:02IHMARKETNEWSNovavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple..
10/5/202401:00PRNUSNovavax and Sanofi Announce Co-exclusive Licensing Agreement..
25/4/202406:52IHMARKETNEWSSouthwest Shares Tumble 9.6% Post $231 Million 1Q Loss,..
19/4/202406:31IHMARKETNEWSParamount’s Shares Surge Following Sony and Apollo’s Joint..
23/2/202413:02EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
23/2/202410:15EDGAR2Form 20-F - Annual and transition report of foreign private..
15/2/202411:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/2/202414:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202413:29GLOBEDupixent® (dupilumab) FDA Approved as First and Only..
23/1/202406:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202405:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
23/1/202404:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
23/1/202400:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
17/1/202412:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202401:14DJNSanofi Names Brian Foard Head of Specialty-Care Unit
27/12/202310:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202301:25DJNSanofi Ends Drug Program After Late-Stage Trial in Lung..
19/12/202306:28DJNInnate Pharma Shares Rise after Sanofi Exercises Licensing..
12/12/202304:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
11/12/202316:18DJNSanofi Terminates Agreement with Maze Therapeutics Following..
11/12/202300:50DJNSanofi Sees Improvement in Trial Results of Cancer Drug..
07/12/202301:34DJNSanofi Myeloma Drug Sarclisa Met Primary Goal in Late-Stage..
07/12/202301:20DJNSanofi Sees Annual Sales From New Pharma Assets Above $10.8..
06/12/202307:20DJNTrending: Merck's Multiple Sclerosis Drug Misses..
06/12/202304:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
30/11/202308:23DJNTeva Closes Collaboration Deal With Sanofi on IBD Treatment
30/11/202307:30BWTeva Completes Closing of Exclusive Collaboration Deal to..
27/11/202309:31DJNTrending: Sanofi's Notus Trial Meets Primary Endpoint
27/11/202301:40DJNSanofi Says Notus Phase 3 Trial of Dupixent Met Primary..
27/11/202300:30GLOBEDupixent® (dupilumab) Significantly Reduced COPD..
07/11/202315:01APSOrphan Drugs Worth $64 Billion by 2028 and This Micro Cap..
07/11/202307:56DJNSanofi Under Preliminary Probe in France Over Possible..
07/11/202306:10IHMARKETNEWSTuesday’s Wall Street Highlights: WeWork, UBS, Sanofi,..
06/11/202306:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/11/202311:15PRNUSSanofi honors 10 advocacy organizations promoting health..
01/11/202307:45IHNWGet Ready for Next Generation of Diabetes, Weight-Management..
01/11/202306:00PRNUSSanofi launches "The 1 Pledge" movement to drive early..
30/10/202307:14DJNMeiraGTx Gets $30 Million Investment From Sanofi
27/10/202311:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

Delayed Upgrade Clock